"Hematologic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders of the blood and blood forming tissues.
Descriptor ID |
D006402
|
MeSH Number(s) |
C15.378
|
Concept/Terms |
Hematologic Diseases- Hematologic Diseases
- Disease, Hematologic
- Diseases, Hematologic
- Hematologic Disease
- Blood Diseases
- Blood Disease
- Disease, Blood
- Diseases, Blood
- Hematological Diseases
- Disease, Hematological
- Diseases, Hematological
- Hematological Disease
|
Below are MeSH descriptors whose meaning is more general than "Hematologic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Hematologic Diseases".
This graph shows the total number of publications written about "Hematologic Diseases" by people in this website by year, and whether "Hematologic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2007 | 2 | 0 | 2 |
2009 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2017 | 17 | 3 | 20 |
2018 | 9 | 9 | 18 |
2019 | 6 | 2 | 8 |
2020 | 9 | 4 | 13 |
2021 | 6 | 2 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematologic Diseases" by people in Profiles.
-
Feasibility of a Pilot Home Phlebotomy Program for Pediatric Hematology/Oncology Patients During the COVID-19 Pandemic. J Pediatr Hematol Oncol. 2022 Jan 01; 44(1):e185-e187.
-
Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology. 2021 Dec; 26(1):225-239.
-
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease. JAMA Oncol. 2021 11 01; 7(11):1714-1716.
-
Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh. PLoS One. 2021; 16(7):e0255379.
-
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital. Blood Cancer J. 2021 07 14; 11(7):129.
-
Reduction in incidence of non-COVID-19 respiratory virus infection amongst haematology inpatients following UK social distancing measures. Br J Haematol. 2021 10; 195(2):194-197.
-
Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan. Int J Hematol. 2021 Dec; 114(6):719-724.
-
COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience. Br J Haematol. 2021 08; 194(4):e74-e77.
-
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic. Clin Lymphoma Myeloma Leuk. 2021 09; 21(9):606-612.
-
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas. Pediatr Hematol Oncol. 2021 Nov; 38(8):695-706.